-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NE-3107 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NE-3107 in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NE-3107 in Alzheimer's Disease Drug Details: NE-3107 (Triolex, HE3286) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NE-3107 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NE-3107 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NE-3107 in Parkinson's Disease Drug Details: NE-3107 (Triolex, HE3286) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NE-3107 in Mild Cognitive Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NE-3107 in Mild Cognitive Impairment report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NE-3107 in Mild Cognitive Impairment Drug Details: NE-3107 (Triolex, HE3286) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GM-60106 in Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GM-60106 in Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GM-60106 in Fibrosis Drug Details: GM-60106 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GM-60106 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GM-60106 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GM-60106 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: GM-60106...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bezisterim in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bezisterim in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bezisterim in Alzheimer's Disease Drug Details: NE-3107 (Triolex, HE3286) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bezisterim in Mild Cognitive Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bezisterim in Mild Cognitive Impairment report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bezisterim in Mild Cognitive Impairment Drug Details: NE-3107 (Triolex, HE3286)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABBV-400 in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABBV-400 in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABBV-400 in Melanoma Drug Details: ABBV-400 is under development for the treatment...
-
Product Insights
Nes
Nes is a Hydro project located in Akershus, Norway. The project is owned by Akershus Energi AS ; E-CO Energi AS; Vardar AS. The project came online in 1967. Empower your strategies with our Nes report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed...
-
Product Insights
Mui Ne Solar PV Park
Mui Ne Solar PV Park is a solar PV project located in Binh Thuan, Vietnam. The project is owned by Dragon Capital Group Limited; Pacifico Energy K.K. and was developed by Duc Thanh Mui Ne. The project came online in 2019. Empower your strategies with our Mui Ne Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...